TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model
about
P1343
Meta-analysis of prostate cancer gene expression data identifies a novel discriminatory signature enriched for glycosylating enzymesERG is a critical regulator of Wnt/LEF1 signaling in prostate cancerCombined genetic and epigenetic interferences with interferon signaling expose prostate cancer cells to viral infectionTMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cellsEpithelial-mesenchymal transition in prostate cancer: an overview.Identifying global expression patterns and key regulators in epithelial to mesenchymal transition through multi-study integration.The role of TMPRSS2:ERG in molecular stratification of PCa and its association with tumor aggressiveness: a study in Brazilian patients.Molecular pathways and targets in prostate cancerThe role of epithelial plasticity in prostate cancer dissemination and treatment resistanceMeta-analysis of gene expression signatures defining the epithelial to mesenchymal transition during cancer progressionERG rearrangement is associated with prostate cancer-related death in Chinese prostate cancer patientsERG oncoprotein inhibits ANXA2 expression and function in prostate cancermiR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers.Oncogenic activation of ERG: A predominant mechanism in prostate cancer.The transcription factor ERG increases expression of neurotransmitter receptors on prostate cancer cells.Comprehensive serial molecular profiling of an "N of 1" exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatmentOverexpression of ETV4 is oncogenic in prostate cells through promotion of both cell proliferation and epithelial to mesenchymal transitionIntegrin-linked kinase as a target for ERG-mediated invasive properties in prostate cancer models3D Porous Chitosan-Alginate Scaffolds as an In Vitro Model for Evaluating Nanoparticle-Mediated Tumor Targeting and Gene Delivery to Prostate Cancer.Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer.ERG/AKR1C3/AR Constitutes a Feed-Forward Loop for AR Signaling in Prostate Cancer CellsAn EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530).The impact of genetic variants in inflammatory-related genes on prostate cancer risk among men of African Descent: a case control study.Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions.Androgen receptor and gene network: Micromechanics reassemble the signaling machinery of TMPRSS2-ERG positive prostate cancer cells.Evolutionary functional analysis and molecular regulation of the ZEB transcription factors.Recent updates on the role of microRNAs in prostate cancer.TMPRSS2-ERG Fusion Gene Expression in Prostate Tumor Cells and Its Clinical and Biological Significance in Prostate Cancer ProgressionThe oncogene ERG: a key factor in prostate cancer.High alpha-methylacyl-CoA racemase (AMACR) is associated with ERG expression and with adverse clinical outcome in patients with localized prostate cancer.microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patients.Involvement of NEDD9 in the invasion and migration of gastric cancer.Short hairpin RNA (shRNA) of type 2 interleukin-1 receptor (IL1R2) inhibits the proliferation of human osteosarcoma U-2 OS cells.Serine protease inhibitor Kazal type 1 promotes epithelial-mesenchymal transition through EGFR signaling pathway in prostate cancer.ERG-SOX4 interaction promotes epithelial-mesenchymal transition in prostate cancer cells.TMPRSS2-ERG gene fusions induce prostate tumorigenesis by modulating microRNA miR-200c.Identification of novel TMPRSS2:ERG mechanisms in prostate cancer metastasis: involvement of MMP9 and PLXNA2.Overexpression of ZEB1 associated with metastasis and invasion in patients with gastric carcinoma.Roles of Grainyhead-like transcription factors in cancer.
P2860
Q28085759-B0499130-9C57-4ABA-B6CB-6CFD702AE90DQ28771736-424A3070-C279-405C-88C5-46246631DC63Q28817152-0C22A635-7395-4FF6-A087-20656391C7ACQ33648775-A8645C1E-A886-411A-99B9-219FDF503AF4Q33798864-B64EC2DF-220F-421A-BF9A-3C862ACE3ED8Q33837764-F0B80A67-889F-4922-A381-E1803A9CB71EQ33876961-E682DE7C-BCD0-4114-86DA-1E9ECB88E17FQ34365632-721A92B1-EC4B-4A40-8123-38B76CE7EE3AQ34505037-34407C13-2DE4-489A-960B-05C67A1B18CBQ34516160-8EC38634-2665-4582-9109-6F2456664673Q35091321-728B8DA0-4D60-4BBC-BA25-E0937782F68AQ35108911-97A3A853-E853-4390-AF93-589F106EC64AQ35207623-F1A23796-275E-4AD2-908D-FD239A046CACQ35510445-F86E3650-B9AA-474C-94A0-7DDE4C109600Q35685920-C05E922C-9ACA-42A5-85E4-70E7B8D4EA4FQ35756563-FD25DF2A-C48E-4BBD-9508-9994585E3A5BQ36131601-11689947-BDA5-4049-A122-02CF656D1600Q36143137-A3C8F058-8AD9-4134-953B-A2FCCEF82FDCQ36435777-33A0923C-2113-4809-9510-D6BBBAC79C53Q36798100-17A6870E-959B-44C4-8F4C-15977C2052DCQ36848024-4117AE98-211F-4E0D-869B-B5DDEB27FF69Q37157965-81BDF71F-6B86-4D65-A88F-BC5CAC1BD5D7Q37357076-B0677C59-A110-45CF-BB9B-67C0E7C1BDB7Q37593392-A77D7D6B-8BDA-4068-8B9F-30493EF36162Q37681322-93F414AA-2C5D-4FD3-8168-71C9B04F0637Q37727814-32F5DD5B-9046-4C59-8F9D-C7FFF7476737Q37986328-0981AA29-34CD-40AD-BAB8-6D4500D43C17Q37993624-3336E447-BE46-4CF7-AC51-0B5B8980EF32Q38069582-DB2E9277-08A3-4CAC-9D54-99D9C90A1F30Q38444138-FEB2A669-B963-4EFE-8B34-8D0A6FBAD843Q38737037-9B73DD1A-AA56-4FD5-B94C-E67FE71EC71FQ38791639-F5CB958C-E455-4D64-81EC-7A89B7690F6FQ38921263-9D00FE5B-2559-496E-93E7-A75AF2BEFA26Q38937091-87FA1673-78D8-4B34-BB44-D7E1574E58D3Q39016331-27F7B46B-9275-4C7E-803F-0B2A6D39EC61Q39033577-AFD23D0F-7265-4FCD-BFA2-9425FB837668Q39067486-D0D127E5-F48F-407F-AEF4-DDBD6D2E1CC7Q39147275-DF482C73-9C0A-491D-856A-16163E9C8950Q39371051-00706F76-42B2-4E4C-B076-B38599CBBF78Q39438840-1409AB78-B991-4FF6-B59C-45ABA765037A
P2860
TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
TMPRSS2/ERG promotes epithelia ...... xis in a prostate cancer model
@ast
TMPRSS2/ERG promotes epithelia ...... xis in a prostate cancer model
@en
TMPRSS2/ERG promotes epithelia ...... xis in a prostate cancer model
@nl
type
label
TMPRSS2/ERG promotes epithelia ...... xis in a prostate cancer model
@ast
TMPRSS2/ERG promotes epithelia ...... xis in a prostate cancer model
@en
TMPRSS2/ERG promotes epithelia ...... xis in a prostate cancer model
@nl
prefLabel
TMPRSS2/ERG promotes epithelia ...... xis in a prostate cancer model
@ast
TMPRSS2/ERG promotes epithelia ...... xis in a prostate cancer model
@en
TMPRSS2/ERG promotes epithelia ...... xis in a prostate cancer model
@nl
P2093
P2860
P50
P3181
P1433
P1476
TMPRSS2/ERG promotes epithelia ...... xis in a prostate cancer model
@en
P2093
Ephraim Gazit
Ira Kogan-Sakin
Iris Kamer
Jasmine Jacob-Hirsch
Marcelo Ehrlich
Naomi Goldfinger
Orit Leshem
Raanan Berger
Ron Loewenthal
Shalom Madar
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0021650
P407
P4510
P577
2011-01-01T00:00:00Z